Vikram Deshpande

Beth Israel Deaconess Medical Center — United States

Medicine · Health Sciences

114h-index57.2kcitations961works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(168), Immunotherapy and Immune Responses(133), Neuroendocrine Tumor Research Advances(123), vaccines and immunoinformatics approaches(112), Cholangiocarcinoma and Gallbladder Cancer Studies(111)

Publications905 total

Thinking like a pathologist: anatomy-anchored artificial intelligence for liver pathology
Journal of Clinical Pathology·2025
Claudin 18.2 in cancer research and treatment: a pathologist’s perspective
Journal of Clinical Pathology·2025
Advancing the diagnosis of IgG4-related ophthalmic disease: a critical appraisal of current criteria
Journal of Clinical Pathology·2025
Towards generalisable and equitable artificial intelligence in pathology
Journal of Clinical Pathology·2025
Figure 1 FS1 from FGFR mRNA Expression in Cholangiocarcinoma and Its Correlation with <i>FGFR2</i> Fusion Status and Immune Signatures
2025Open Access
Industry 4.0 solutions to address paradoxical effect of flexible work arrangements: tri-dimensional review and forward outlook
Environment Development and Sustainability·2025
Cell line-specific estrogen responses uncover functional sex differences in murine macrophages
Biology of Sex Differences·2025· 2 citedOpen Access
WHO is embedding inequality into cancer diagnostics
BMJ Oncology·2025Open Access
Abstract B117: Intraductal Papillary Mucinous Neoplasm Cellular Plasticity Linked with Repeat Element Dysregulation
Cancer Research·2025
S-AIR Score for Prediction of Likelihood of Obstructive Sleep Apnoea (OSA) in Indian Population.
2025
Supplementary Table S4 from Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets
2025Open Access
Supplementary Figures S1-S9 from Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets
2025Open Access
Supplementary Table S3 from Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets
2025Open Access
Supplementary Table S9 from Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets
2025Open Access
Supplementary Table S7 from Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets
2025Open Access
Supplementary Table S6 from Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets
2025Open Access
Supplementary Table S1 from Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets
2025Open Access
Supplementary Table S2 from Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets
2025Open Access
Data from Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets
2025Open Access
Supplementary Table S5 from Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets
2025Open Access
page 1 of 46Next →

Frequent Co-authors

John H. Stone(16), Nabeel Bardeesy(14), Mollie N. Carruthers(9), Arezou Khosroshahi(8), David T. Ting(8), Andrew X. Zhu(7), Cristina R. Ferrone(6), Ömer Yılmaz(6), Miguel N. Rivera(6), William R. Brugge(5), Carlos Fernández‐del Castillo(5), James R. Stone(5), David P. Ryan(5), Julien Fitamant(5), Mari Mino–Kenudson(5), Zachary S. Wallace(5), Hamid Mattoo(5), Vinay S. Mahajan(5), Shiv Pillai(5), Rehan Akbani(5)